Leukemia
A Global Multicenter, Open Label, Randomized, Phase 3 Registrational Study of Olverembatinib (HQP1351) in Patients with Chronic Phase Chronic Myeloid Leukemia (POLARIS-2)(HQP1351CG301)
- Details
ClinicalTrials.gov ID:
NCT06423911
Diagnosis Type:
NA
USOR Number:
- Address
,
P: